News
-
Vectura has announced the appointment of Sharon Johnson to the newly created position of Executive VP for Delivery Management “to support innovation, customer focus and growth as the company continues with its strategic development as… Read more . . .
-
Nanoform, a specialist in nanonization technology, has announced the establishment of a wholly owned US subsidiary, citing growing demand for its technology from US pharma companies. Nanoform recently announced the appointment of former Catalent executive… Read more . . .
-
Apollo Global Management has agreed to acquire Covis Pharma, which markets several ciclesonide aerosol products: the Alvesco MDI and Omnaris and Zetonna nasal sprays. Terms of the deal were not disclosed. Covis is currently owned… Read more . . .
-
Boehringer Ingelheim’s reusable Respimat soft mist inhaler has won the 2020 Pharmapack Eco-Design Award, the company said. As many as six medication cartridges can be used with this version of the Respimat before the device must… Read more . . .
-
Inhaled insulin developer Aerami Therapeutics (formerly Dance Biopharm) has announced the appointment of Timm Crowder as Chief Operating Officer. Crowder, who was most recently Chief Operating Officer of Spyryx Biosciences, was a co-founder of DPI… Read more . . .
-
Drug delivery device maker Nemera said that its Safe’n’Spray concept intranasal device has won the “Best Innovation In Drug Delivery Device” Award at Pharmapack. In addition to being a connected device that allows for usage… Read more . . .
-
Koura (formerly Mexichem Fluor) announced that the FDA has cleared the company’s IND for Zephex HFA 152a MDI propellant, and the company plans to initiate clinical trials of the propellant this month. In December 2019,… Read more . . .
-
Verona Pharma has announced the appointment of former United Therapeutics executive David Zaccardelli as President and CEO, succeeding Jan-Anders Karlsson, who is retiring. Zaccardelli was most recently President and CEO of Dova Pharmaceuticals, which was… Read more . . .
-
The EMA has announced that its Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion regarding a marketing authorization application submitted by Teva Pharma B.V. for a budesonide/formoterol DPI for the… Read more . . .
-
Pulmatrix has announced that its Pulmazole (PUR1900) dry powder itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in patients with asthma has received Fast Track designation from the FDA. The company initiated a Phase… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.